Atlas Trials

A Study of LY3437943 in Participants With Impaired and Normal Liver Function

Clinical trial NCT05916560 · COMPLETED

Trial details

NCT number
NCT05916560
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
HealthyHepatic Insufficiency
Start date
2023-07-13
Primary completion
2025-03-02
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.